The Justice Department and Drug Enforcement Administration announced April 23 that FDA-approved marijuana products and medical marijuana products covered by a qualifying state-issued license have been moved to Schedule III of the Controlled Substances Act, a significant loosening of federal restrictions on the drug for medical use.
The order, issued by Acting Attorney General Todd Blanche, carries out President Donald Trump's Dec. 18, 2025 executive order calling for expanded research into medical marijuana and cannabidiol.
Recent comments
8 weeks 4 days ago
9 weeks 12 min ago
17 weeks 23 hours ago
18 weeks 2 days ago
19 weeks 4 hours ago
24 weeks 2 days ago
30 weeks 4 days ago
30 weeks 5 days ago
33 weeks 5 days ago
34 weeks 5 days ago